Kimberly Wilson

Kimberly Wilson is currently an advisor at COTA Healthcare. Kimberly has previous experience working as a Sr. Director Real World Evidence, Informatics & Predictive Sciences at Celgene from January 2017 to November 2019 and as a Director, Epidemiology Immuno-Oncology at Bristol Myers Squibb from November 2015 to January 2017. Wilson also has experience working as a Sr Informatics Scientist at Merck from October 2009 to November 2015.

Kimberly Wilson has a MS in Epidemiology from the University of Cincinnati and a BA in Biology and Spanish from Hiram College.